Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Garber

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Diabetes, Obesity & Metabolism|December 22, 2005
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)A J Garber, J Wahlen, T Wahl, et al.
The American Journal of Medicine|January 16, 1998
Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trialA J Garber, T G Duncan, A M Goodman, et al.
Geriatrics|April 1, 1983
Managing cardiac disease in patients with diabetes mellitusS R Mather, A J Garber, M Attar, et al.
Journal of Cyclic Nucleotide Research|January 1, 1981
[125I]iodopindolol: a new beta adrenergic receptor probeE G Ezrailson, A J Garber, P J Munson, et al.
The Journal of Clinical Investigation|July 1, 1976
The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in manA J Garber, P E Cryer, J V Santiago, et al.
Diabetes, Obesity & Metabolism|April 13, 2013
Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agentsA Philis-Tsimikas, S Del Prato, I Satman, et al.
Metabolism: Clinical and Experimental|December 1, 1980
The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetesB S Keenan, R T Kirland, A J Garber, et al.
Diabetes, Obesity & Metabolism|February 21, 2008
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylureaA J Garber, J E Foley, M A Banerji, et al.
Advances in Cyclic Nucleotide Research|January 1, 1978
Sarcoplasmic reticulum: a potential internal cyclic AMP effector site and beta-adrenergic receptorM L Entman, E P Bornet, W B Van Winkle, et al.
Diabetes, Obesity & Metabolism|November 26, 2009
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissueJ Jendle, M A Nauck, D R Matthews, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Diabetes, Obesity & Metabolism|December 22, 2005
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)A J Garber, J Wahlen, T Wahl, et al.
The American Journal of Medicine|January 16, 1998
Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trialA J Garber, T G Duncan, A M Goodman, et al.
Geriatrics|April 1, 1983
Managing cardiac disease in patients with diabetes mellitusS R Mather, A J Garber, M Attar, et al.
Journal of Cyclic Nucleotide Research|January 1, 1981
[125I]iodopindolol: a new beta adrenergic receptor probeE G Ezrailson, A J Garber, P J Munson, et al.
The Journal of Clinical Investigation|July 1, 1976
The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in manA J Garber, P E Cryer, J V Santiago, et al.
Diabetes, Obesity & Metabolism|April 13, 2013
Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agentsA Philis-Tsimikas, S Del Prato, I Satman, et al.
Metabolism: Clinical and Experimental|December 1, 1980
The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetesB S Keenan, R T Kirland, A J Garber, et al.
Diabetes, Obesity & Metabolism|February 21, 2008
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylureaA J Garber, J E Foley, M A Banerji, et al.
Advances in Cyclic Nucleotide Research|January 1, 1978
Sarcoplasmic reticulum: a potential internal cyclic AMP effector site and beta-adrenergic receptorM L Entman, E P Bornet, W B Van Winkle, et al.
Diabetes, Obesity & Metabolism|November 26, 2009
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissueJ Jendle, M A Nauck, D R Matthews, et al.
Pageof 10